Platinum resistance
Similar chromosomal changes in cisplatin resistant and oxaliplatin resistant sublines of the H69 SCLC cell line are not associated with platinum resistance
29
Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance
15
Copper transporting P type adenosine triphosphatase (ATP7A) is associated with platinum resistance in non small cell lung cancer (NSCLC)
9
Acquired platinum resistance involves epithelial to mesenchymal transition through ubiquitin ligase FBXO32 dysregulation
16
Secondary BRCA1 Mutations in BRCA1-Mutated Ovarian carcinomas with platinum resistance.
26
A metabolomic approach to identifying platinum resistance in ovarian cancer
14
RING domain–deficient BRCA1 promotes PARP inhibitor and platinum resistance
14
<p>Reversing platinum resistance in ovarian cancer multicellular spheroids by targeting Bcl-2</p>
10
The Platinum Resistance Thermometer78-87
10
Recent Advances in Industrial Platinum Resistance Thermometry42-47
6
Thick Film Platinum Resistance Temperature Detectors2-11
10
Platinum resistance in breast and ovarian cancer cell lines
11
A Thick Film Platinum Resistance Thermometer42-47
6
ATP11B mediates platinum resistance in ovarian cancer
13
The Origin of the Platinum Resistance Thermometer104-112
9
Oxaliplatin for the treatment of cisplatin resistant cancer: A systematic review
25
ERCC1 expression and RAD51B activity correlate with cell cycle response to platinum drug treatment not DNA repair
28
THE EFFECTS OF ERCC1 EXPRESSION LEVELS ON THE CHEMORESISTANCE OF BREAST CANCER PATIENTS TREATED WITH PLATINUM BASED ADJUVANT CHEMOTHERAPY
6
Voltammetric and Impedance studies of Phenols and Its Derivatives at Carbon Nanotubes/Prussian Blue Films Platinum Modified Electrode
17
Original Article Clinical study on personalized treatment for advanced NSCLC guided by ERCC1 protein detection
8